Back to dashboard
Episode 256
DIP Episode 256 - USMLE Step 2CK Rapid Review Series 41 (and Step 2CK 10 hr Course 9/5/20)
MixedMedium4 - HighHas Q&A
Step 1Step 2Step 3COMLEXMedicineUSMLEStep 1Step 2Step 3
Topic
Lymphoma (Burkitt, Hodgkin); Hepatocellular Carcinoma; Perineoplastic Syndromes (SIADH, H.O.A., LEMS); Lung Cancer Pathophysiology & Markers...
Key Takeaway
The board exam frequently tests the association between specific malignancies and associated paraneoplastic syndromes, tumor markers, or characteristic imaging/histological findings (e.g., EBV with Burkitt lymphoma, PTHrP with Squamous Cell Lung Cancer).
Runtime: 20.8 min
Published: 2020-08-24
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW SERIES
Episode Notes
Source / episode info
- Episode: 256
- Title: Divine Intervention Episode 256 – USMLE Step 2 CK Rapid Review Series 41 (and Step 2 CK 10 hr Course 9/5/20).
- Published: 2020-08-24
- Source: Episode page
One-liner
This episode is a high-yield review of basic science concepts for the USMLE Step 2 CK exam, emphasizing associations between malignancies and paraneoplastic syndromes (e.g., SIADH, H.O.A.), tumor markers (AFP, CEA), characteristic calcified masses in neuroimaging, and specific histological patterns (Burkitt lymphoma).
High-yield summary
- EBV Associations: EBV is strongly associated with Burkitt Lymphoma (t(8;14)), Hodgkin's Lymphoma, Nasopharyngeal Carcinoma, and Primary CNS Lymphoma (especially in HIV+ patients).
- HCC Risk: Chronic exposure to grains/aflatoxins leads to Hepatocellular Carcinoma (HCC), which is a critical association for liver pathology.
- Perineoplastic Syndromes: Lung cancer can cause multiple syndromes: SIADH (hyponatremia, hypertonic urine >1.012 SG), Hypertrophic Osteoarthropathy (H.O.A.), and Lambert-Erythroasthenic Syndrome (LEMS).
- Calcified Masses: Calcification in the meninges/brain is highly specific: Hemangioblastoma (cerebellum, calcified mass) vs. Craniopharyngioma (pituitary stalk, calcified mass) vs. Oligodendroglioma (frontal lobe, calcified mass).
- Tumor Markers: Specific markers are associated with primary sites: AFP (Yolk Sac Tumor, HCC), CA-125 (Ovarian Cancer), CEA (Colorectal/Pancreatic), and PSA (Prostate Cancer).
Learning objectives
- Identify the key associations between common malignancies and their associated paraneoplastic syndromes (e.g., SIADH, H.O.A.).
- Differentiate the clinical presentation and imaging findings of various calcified intracranial masses (Hemangioblastoma vs. Craniopharyngioma).
- Interpret tumor markers (AFP, CEA, CA-125, PSA) to suggest a primary site of malignancy.
- Recognize the characteristic histology and genetics of lymphomas like Burkitt lymphoma.
- Understand the pathophysiology of paraneoplastic hypercalcemia from various sources (PT HrP, Sarcoidosis, Multiple Myeloma).
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Burkitt Lymphoma | Starry sky pattern; t(8;14) translocation. | EBV; Burkitt's macassar. | Always link this triad together on the exam. |
| Small Cell Lung Cancer (SCLC) | High urine specific gravity (>1.012); low cortisol response to dexamethasone. | SIADH, Lambert-Erythroasthenic Syndrome (LEMS). | Remember SCLC is highly neuroendocrine and often aggressive; treatment is chemo/radiation. |
| Hemangioblastoma | Calcified mass in the cerebellum or posterior fossa. | Neuroblastoma (in infants); Arachnoid cyst (anterior midline). | If calcification is seen, think of a differential diagnosis based on location. |
| HCC | Aflatoxin exposure; elevated AFP/ALT. | Chronic liver disease (cirrhosis). | HCC development must be considered in any patient with chronic liver disease and risk factors like aflatoxins. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Burkitt Lymphoma | t(8;14) translocation; Starry sky pattern. | B-cell lymphoma, highly proliferative. | High yield for genetics and histology in board exams. |
| HCC/Aflatoxins | Aflatoxin exposure -> HCC. | Chronic liver disease risk factor. | Links environmental toxicology to malignancy development. |
| Paraneoplastic Hypercalcemia | PT HrP (Squamous Cell Lung Cancer); IL-1 (Multiple Myeloma). | Bone resorption; elevated serum calcium. | Requires knowing the source of excess PTH action, not just high Ca++. |
| Calcified Brain Mass | Hemangioblastoma in cerebellum; Craniopharyngioma near pituitary stalk. | Differential diagnosis based on location and age/sex. | Calcification is a major clue; always list differentials. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A child with a jaw mass, t(8;14) translocation, starry sky pattern. | Burkitt Lymphoma | The classic genetic and histological triad for this highly proliferative B-cell lymphoma. |
| Patient exposed to grains/aflatoxins develops liver mass on ultrasound. | Hepatocellular Carcinoma (HCC) | Aflatoxin exposure is the most common environmental risk factor leading to HCC, especially in endemic areas. |
| Lung cancer patient with joint pain and digital clubbing; next step is CXR/CT. | Hypertrophic Osteoarthropathy (H.O.A.) | H.O.A. is a classic paraneoplastic syndrome of underlying malignancy, requiring imaging to find the primary source. |
| Small blue cells positive for chromogranin and found in lung cancer. | Small Cell Lung Cancer (SCLC) | SCLC often has neuroendocrine features; Chromogranin positivity supports this diagnosis. |
| Calcified mass in the cerebellum causing morning headaches/nausea. | Hemangioblastoma | This is the classic location and appearance of a calcified tumor, often associated with subarachnoid hemorrhage risk. |
| A woman with an adnexal mass; CT suggests adrenal source for hyperandrogenism. | Hyperinidrogenism (Adrenal Tumor) | The initial workup must rule out adrenal sources (e.g., adenoma) before assuming ovarian origin, especially when testosterone is normal. |
Differential diagnosis / distinguishing features
Hyperandrogenism Workup
| Key Features | Distinguishing Findings | Next Step |
| Ovarian Source (e.g., Granulosa Cell Tumor) | Estrogen production; precocious puberty in girls, or endometrial hyperplasia/cancer risk. | Biopsy of the adnexal mass; measure estrogen levels. |
| Adrenal Source (e.g., Adenoma) | High DHEA-S; adrenal tumor is the primary source of excess androgens. | CT scan of abdomen/pelvis to image adrenal glands. |
Management pearls
- HCC Workup: In any patient with chronic liver disease, perform screening for HCC (ultrasound/AFP) due to high risk from aflatoxin exposure.
- Paraneoplastic Hypercalcemia: Always determine the source of PTH excess: Primary hyperparathyroidism (PTH), Malignancy (PT HrP or IL-1), or Granulomatous Disease (Vitamin D activation).
- SCLC Management: Due to its aggressive nature, SCLC is typically treated with chemotherapy and radiation; surgery is rarely curative.
- Calcified Brain Mass Workup: The location of the calcification dictates the differential diagnosis (e.g., posterior fossa suggests Hemangioblastoma; suprasellar suggests Craniopharyngioma).
Don't miss
🚨
EBV Association: Remember EBV's association with Burkitt, Hodgkin, and Nasopharyngeal Carcinoma.
🚨
HCC Risk Factor: Aflatoxin exposure is a major risk factor for HCC development in the context of chronic liver disease.
🚨
Paraneoplastic Syndromes: Be ready to link specific cancers (e.g., Squamous Cell Lung Cancer -> PT HrP) to their resulting endocrine/metabolic derangements.
🚨
Tumor Marker Interpretation: Markers like PSA, CEA, and CA-125 are primarily used for monitoring response to therapy, not initial diagnosis.
Integration & clinical reasoning
- Endocrine Integration (Hypercalcemia): The mechanism of hypercalcemia is often the most tested aspect: PT HrP mimics PTH action; IL-1/Osteoclast Activating Factor stimulates osteoclasts; Sarcoidosis involves activated macrophages producing 1-\alpha-hydroxylase.
- Oncology Integration (Lung Cancer): Lung cancer is a major source of paraneoplastic syndromes, including SIADH (SCLC), H.O.A., and LEMS.
- Neuroimaging Integration: Calcified masses are highly specific; the location dictates the differential diagnosis (e.g., posterior fossa vs. suprasellar).
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- Standard emergency management takes priority over OMM/OMT in acute crises (e.g., severe electrolyte imbalance from SIADH or acute liver failure).
- The understanding of systemic inflammation and cytokine release (IL-1, TNF-\alpha) is relevant to the pathophysiology of Multiple Myeloma hypercalcemia and general inflammatory states.
Concept connections / cross-references
- For detailed information on liver pathology and HCC screening, see [Episode 12].
- For comprehensive review of endocrine emergencies like adrenal insufficiency or hypercalcemia, see [Episode 45].
- For general oncology principles and tumor markers, see [Episode 88].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Burkitt Lymphoma | EBV; t(8;14) translocation. | High proliferation rate due to genetic instability. | Classic triad (EBV/t(8;14)/Starry Sky) must be recognized. |
| Squamous Cell Lung Cancer | PT HrP production. | Parathyroid hormone-related peptide mimics PTH, causing hypercalcemia and hypophosphatemia. | Hypercalcemia is a common paraneoplastic finding in this type of lung cancer. |
| Small Cell Lung Cancer (SCLC) | SIADH; Lambert-Erythroasthenic Syndrome (LEMS). | Neuroendocrine activity leading to ADH excess or neuromuscular junction dysfunction. | These syndromes are key diagnostic clues for SCLC. |
| Multiple Myeloma | Interleukin-1 (IL-1) / Osteoclast Activating Factor. | IL-1 stimulates osteoclasts, leading to bone resorption and hypercalcemia. | Hypercalcemia is a common complication of plasma cell dyscrasias. |
Key terms glossary
| Term | Definition | Context | Example |
| Aflatoxin | Toxic mycotoxins produced by Aspergillus mold. | Liver pathology; chronic exposure to contaminated grains. | Causes HCC and is a major risk factor for liver cancer. |
| Hypertrophic Osteoarthropathy (H.O.A.) | Joint pain, clubbing, and periosteal new bone formation in the long bones. | Paraneoplastic syndrome of underlying malignancy (e.g., lung cancer). | Requires imaging to find the primary source of cancer. |
| Interleukin-1 (IL-1) | A pro-inflammatory cytokine/osteoactivator. | Multiple Myeloma; bone pathology. | Acts as an osteoclast activator, leading to pathological bone breakdown and hypercalcemia. |
| Chromogranin | Neuroendocrine protein marker. | Small Cell Lung Cancer (SCLC); neuroendocrine tumors. | Positive staining supports a diagnosis of neuroendocrine origin. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Paraneoplastic Syndromes | Create flowcharts linking cancer type -> hormone/cytokine -> resulting syndrome. | High (Board-level association questions). | Review specific associations: SCLC -> SIADH; Squamous LC -> PT HrP. |
| Calcified Masses | Use a differential diagnosis table based on the location of calcification in neuroimaging. | Medium-High (Pattern recognition/Vignette traps). | Memorize key locations: Cerebellum (Hemangioblastoma); Suprasellar (Craniopharyngioma). |
| Tumor Markers | Understand that markers are for monitoring, not diagnosis; know the primary source marker. | Medium (Common trap question area). | PSA is used to monitor treatment response in prostate cancer. |
Question pattern recognition
- Pattern: Calcified mass in the cerebellum/posterior fossa -> Hemangioblastoma. This is a classic location and appearance for this tumor, often associated with subarachnoid hemorrhage risk.
- Pattern: Hypercalcemia + Malignancy -> Check PT HrP source first. If PT HrP is high, suspect Squamous Cell Lung Cancer or other malignancies; if IL-1/PTH action is suspected, consider Multiple Myeloma.
- Pattern: Adnexal mass in a woman with hyperandrogenism and normal testosterone -> Rule out adrenal sources (CT abdomen) before assuming ovarian origin. This prevents missing an adrenal adenoma.
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Assuming all calcifications are benign. Calcification in the brain/meninges requires a differential diagnosis (Hemangioblastoma vs. Craniopharyngioma vs. Oligodendroglioma) based on location and age.
🚫
Mistake 2: Confusing tumor marker utility. Never use markers like PSA or CEA to diagnose cancer; they are primarily for monitoring treatment response.
🚫
Mistake 3: Reversing the hypercalcemia mechanism. Remember that PT HrP (Squamous LC) and IL-1 (Multiple Myeloma) both cause bone resorption, leading to high calcium, but their sources are different.
Common traps
⚠️
Trap 1 (Calcification): The location of calcification is key. Posterior fossa/cerebellum suggests Hemangioblastoma; suprasellar suggests Craniopharyngioma.
⚠️
Trap 2 (Tumor Markers): Do not assume that a positive tumor marker confirms the diagnosis or guides initial therapy—it is mainly for monitoring.
⚠️
Trap 3 (Adrenal Source): When hyperandrogenism occurs, always rule out an adrenal source (CT abdomen) before attributing it solely to ovarian pathology.